Advanced or metastatic ER+ HER2- breast cancer (MBC)

Clinical trials for Advanced or metastatic ER+ HER2- breast cancer (MBC) explained in plain language.

Never miss a new study

Get alerted when new Advanced or metastatic ER+ HER2- breast cancer (MBC) trials appear

Sign up with your email to follow new studies for Advanced or metastatic ER+ HER2- breast cancer (MBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New cancer drug OP-3136 enters first human tests

Disease control Recruiting now

This early-phase study tests a new drug called OP-3136 in people with advanced breast, lung, or prostate cancers that have not responded to other treatments. The drug works by blocking certain enzymes that help cancer cells grow. The study will first find a safe dose, then test i…

Matched conditions: ADVANCED OR METASTATIC ER+ HER2- BREAST CANCER (MBC)

Phase 1 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

Advanced or metastatic ER+ HER2- breast cancer (MBC)

Get alerted when new Advanced or metastatic ER+ HER2- breast cancer (MBC) trials appear

New cancer drug OP-3136 enters first human tests